Page last updated: 2024-10-17

n(1)-methylnicotinamide and Pulmonary Hypertension

n(1)-methylnicotinamide has been researched along with Pulmonary Hypertension in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Research Excerpts

ExcerptRelevanceReference
"Progression of pulmonary hypertension is associated with the activation of the NNMT-MNA pathway in rats and humans."1.43Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension. ( Chlopicki, S; Fedorowicz, A; Jakubowski, A; Kopec, G; Kutryb-Zając, B; Mateuszuk, Ł; Skórka, T; Słomińska, E; Walczak, M; Zakrzewska, A; Łomnicka, M, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fedorowicz, A1
Mateuszuk, Ł1
Kopec, G1
Skórka, T1
Kutryb-Zając, B1
Zakrzewska, A1
Walczak, M1
Jakubowski, A1
Łomnicka, M1
Słomińska, E1
Chlopicki, S1

Other Studies

1 other study available for n(1)-methylnicotinamide and Pulmonary Hypertension

ArticleYear
Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Respiratory research, 2016, 08-31, Volume: 17, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Animals; Case-Control Studies; Disease Models, Animal; Disease

2016